# Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis

> **NCT03701841** · — · UNKNOWN · sponsor: **Anhui Provincial Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Chemotherapy-induced Neutropenia

## Interventions

- **DRUG:** PEG-rhG-CSF

## Key facts

- **NCT ID:** NCT03701841
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2018-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03701841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03701841, "Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03701841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*